Gastroenterology for Medical Students

Gastroenterology is the medical specialty focused on the digestive system, spanning from the esophagus to the rectum, and includes accessory organs like the liver and pancreas. Mastering its core disorders is essential because gastrointestinal (GI) complaints are among the most common reasons patients seek medical care. You will encounter these conditions across all clinical settings, from the emergency department managing a severe bleed to the outpatient clinic discussing cancer screening. A solid grasp of gastroenterology equips you to diagnose effectively, initiate appropriate management, and understand when to urgently refer to a specialist.

Upper Gastrointestinal Disorders: GERD and PUD

Two of the most prevalent upper GI conditions are gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD). GERD is defined by troublesome symptoms or complications resulting from the reflux of stomach contents into the esophagus. Heartburn and regurgitation are classic, but it can manifest atypically as chronic cough, laryngitis, or asthma. First-line management involves lifestyle modifications (weight loss, elevating the head of the bed, avoiding triggers) and a trial of proton pump inhibitors (PPIs). Persistent symptoms despite PPI therapy warrant an esophagogastroduodenoscopy (EGD) to evaluate for complications like erosive esophagitis, strictures, or Barrett's esophagus, a metaplastic change that increases the risk of adenocarcinoma.

PUD involves a breach in the mucosa of the stomach or duodenum, extending into the submucosa. The two primary causes are Helicobacter pylori infection and the use of nonsteroidal anti-inflammatory drugs (NSAIDs). A patient presents with epigastric pain, often described as burning, which may improve (duodenal ulcer) or worsen (gastric ulcer) with food. Diagnosis hinges on identifying the cause. Non-invasive testing for H. pylori via stool antigen or urea breath test is first-line. An EGD is indicated for patients with "alarm features" such as unintentional weight loss, GI bleeding, anemia, or dysphagia, as it allows for direct visualization, biopsy (to rule out malignancy in gastric ulcers), and H. pylori testing. Eradication therapy for H. pylori involves a multi-drug regimen, while NSAID-induced ulcers require PPI therapy and discontinuation of the offending agent.

Inflammatory and Pancreatic Conditions: IBD and Pancreatitis

Moving down the tract, inflammatory bowel disease (IBD) is a chronic, immune-mediated condition with two main subtypes: Crohn's disease and ulcerative colitis. Crohn's can affect any part of the GI tract from mouth to anus, often transmurally and in a discontinuous (skip lesion) pattern. Ulcerative colitis is limited to the colon and rectum, involving the mucosa and submucosa in a continuous fashion from the rectum proximally. Patients present with diarrhea (often bloody in colitis), abdominal pain, weight loss, and fatigue. Diagnosis requires a combination of endoscopic evaluation with biopsy, imaging (like CT or MRI enterography), and laboratory studies to rule out infectious causes. Management is stepped, ranging from 5-aminosalicylates for mild-moderate colitis to immunomodulators (azathioprine), biologics (anti-TNF agents), and surgery for severe or refractory disease.

Pancreatitis is inflammation of the pancreas. The mnemonic "GET SMASHED" (Gallstones, Ethanol, Trauma, Steroids, Mumps, Autoimmune, Scorpion sting, Hypertriglyceridemia, ERCP, Drugs) covers common causes, with gallstones and alcohol accounting for the vast majority. Patients present with severe, constant epigastric pain radiating to the back, often with nausea and vomiting. Diagnosis requires two of three criteria: (1) characteristic abdominal pain, (2) serum amylase/lipase >3x the upper limit of normal, and (3) characteristic findings on imaging (contrast-enhanced CT is the gold standard for assessing severity). Initial management is supportive: aggressive IV fluid resuscitation, pain control, and no oral intake ("NPO") to rest the pancreas.

Hepatic Disease and the Spectrum to Cirrhosis

Liver disease encompasses a wide spectrum. It often begins with hepatocellular injury (e.g., from viral hepatitis, alcohol, or non-alcoholic fatty liver disease) or cholestasis. Persistent injury leads to fibrosis, which can progress to cirrhosis—the irreversible, end-stage scarring of the liver characterized by distorted architecture and regenerative nodules. Cirrhosis is functionally divided into compensated and decompensated stages. Decompensation is marked by the development of life-threatening complications: ascites (fluid in the peritoneal cavity), hepatic encephalopathy (confusion from toxin buildup), and variceal hemorrhage. The Model for End-Stage Liver Disease (MELD) score, calculated from bilirubin, creatinine, and INR, objectively quantifies disease severity and is used for transplant prioritization. Management focuses on treating the underlying cause, screening for complications (e.g., ultrasound for hepatocellular carcinoma), and preventing decompensation.

Critical Presentations: GI Bleeding and Cancer Screening

Gastrointestinal bleeding is a classic high-acuity presentation. It is categorized as upper (proximal to the ligament of Treitz), lower, or obscure. A patient with hematemesis (vomiting blood) or melena (black, tarry stools) likely has an upper GI source, such as a peptic ulcer or varices. Hematochezia (bright red blood per rectum) often suggests a lower GI source like diverticulosis or colitis, but a massive upper bleed can also present this way. The initial workup is universal: assess hemodynamic stability with orthostatic vitals, resuscitate with IV fluids and blood products as needed, and correct coagulopathy. An urgent EGD is the diagnostic and therapeutic procedure of choice for suspected upper GI bleeding. For suspected lower GI bleeding, a colonoscopy is typically performed after adequate bowel prep.

Colorectal cancer screening is a cornerstone of preventive gastroenterology. The goal is to detect and remove precancerous adenomatous polyps, thereby preventing cancer. Screening modalities include direct visualization tests (colonoscopy every 10 years, flexible sigmoidoscopy every 5 years) and stool-based tests (annual fecal immunochemical test (FIT), multi-target stool DNA test every 3 years). Colonoscopy remains the gold standard as it allows for diagnosis, biopsy, and polypectomy in a single procedure. For average-risk individuals, screening begins at age 45. A positive non-colonoscopy test must be followed by a timely diagnostic colonoscopy.

Common Pitfalls

1. Treating all abdominal pain the same: A patient with epigastric burning may have GERD, PUD, or even biliary disease. Failing to ask about alarm features or consider atypical presentations of cardiac pain can lead to misdiagnosis. Always correlate symptoms with a thorough history and physical exam.
2. Starting a PPI before testing for H. pylori: In a patient with suspected PUD, initiating a PPI can lead to false-negative results on urea breath and stool antigen tests. If H. pylori testing is planned, it should ideally be done before or weeks after PPI therapy.
3. Misinterpreting liver enzyme patterns: Conflating hepatocellular (AST/ALT) and cholestatic (ALP, GGT) injury patterns can send you down the wrong diagnostic path. A predominantly cholestatic pattern points toward biliary obstruction or disease, not viral hepatitis.
4. Delaying urgent intervention for GI bleeding: Focusing solely on lab work or imaging in an unstable patient with a major GI bleed is dangerous. The priority is resuscitation and rapid consultation with gastroenterology for endoscopic control, which is both diagnostic and therapeutic.

Summary

• GERD and PUD are common upper GI diagnoses; manage GERD with lifestyle and PPIs, and always investigate the cause of PUD (H. pylori vs. NSAIDs), proceeding to EGD for alarm features.
• IBD (Crohn's and Ulcerative Colitis) is a chronic immune-mediated condition diagnosed endoscopically and managed with a stepwise approach from aminosalicylates to biologics.
• Pancreatitis is diagnosed by meeting two of three criteria (pain, elevated enzymes, imaging) and is managed initially with aggressive supportive care (fluids, analgesia, NPO).
• Cirrhosis is the end-stage of chronic liver injury; monitor for and manage its decompensating complications (ascites, encephalopathy, variceal bleeding).
• GI bleeding requires immediate stabilization, followed by urgent endoscopy (EGD for upper, colonoscopy for lower) for diagnosis and treatment.
• Colorectal cancer screening is primarily preventive; colonoscopy is the gold standard, and screening for average-risk individuals now begins at age 45.